Global Radiopharmaceuticals Market Growth 2022-2028
As the global economy mends, the 2021 growth of Radiopharmaceuticals will have significant change from previous year. According to our latest study, the global Radiopharmaceuticals market size is USD million in 2022 from USD 6613.9 million in 2021, with a change of % between 2021 and 2022. The global Radiopharmaceuticals market size will reach USD 11560 million in 2028, growing at a CAGR of 8.3% over the analysis period.
The United States Radiopharmaceuticals market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Radiopharmaceuticals market, reaching US$ million by the year 2028. As for the Europe Radiopharmaceuticals landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Radiopharmaceuticals players cover Bracco Imaging, Bayer, Mallinckrodt, and Nordion, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Radiopharmaceuticals market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Diagnostic Radioisotopes
Therapeutic Radioisotopes
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Oncology
Cardiology
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Bracco Imaging
Bayer
Mallinckrodt
Nordion
Triad Isotopes
Lantheus
IBA Group
GE Healthcare
China Isotope & Radiation
Jubilant Pharma
Eli Lilly
Advanced Accelerator Applications
SIEMENS
Dongcheng
Navidea
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Radiopharmaceuticals Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Radiopharmaceuticals by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Radiopharmaceuticals by Country/Region, 2017, 2022 & 2028
2.2 Radiopharmaceuticals Segment by Type
2.2.1 Diagnostic Radioisotopes
2.2.2 Therapeutic Radioisotopes
2.3 Radiopharmaceuticals Sales by Type
2.3.1 Global Radiopharmaceuticals Sales Market Share by Type (2017-2022)
2.3.2 Global Radiopharmaceuticals Revenue and Market Share by Type (2017-2022)
2.3.3 Global Radiopharmaceuticals Sale Price by Type (2017-2022)
2.4 Radiopharmaceuticals Segment by Application
2.4.1 Oncology
2.4.2 Cardiology
2.4.3 Other
2.5 Radiopharmaceuticals Sales by Application
2.5.1 Global Radiopharmaceuticals Sale Market Share by Application (2017-2022)
2.5.2 Global Radiopharmaceuticals Revenue and Market Share by Application (2017-2022)
2.5.3 Global Radiopharmaceuticals Sale Price by Application (2017-2022)
3 Global Radiopharmaceuticals by Company
3.1 Global Radiopharmaceuticals Breakdown Data by Company
3.1.1 Global Radiopharmaceuticals Annual Sales by Company (2020-2022)
3.1.2 Global Radiopharmaceuticals Sales Market Share by Company (2020-2022)
3.2 Global Radiopharmaceuticals Annual Revenue by Company (2020-2022)
3.2.1 Global Radiopharmaceuticals Revenue by Company (2020-2022)
3.2.2 Global Radiopharmaceuticals Revenue Market Share by Company (2020-2022)
3.3 Global Radiopharmaceuticals Sale Price by Company
3.4 Key Manufacturers Radiopharmaceuticals Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Radiopharmaceuticals Product Location Distribution
3.4.2 Players Radiopharmaceuticals Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Radiopharmaceuticals by Geographic Region
4.1 World Historic Radiopharmaceuticals Market Size by Geographic Region (2017-2022)
4.1.1 Global Radiopharmaceuticals Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Radiopharmaceuticals Annual Revenue by Geographic Region
4.2 World Historic Radiopharmaceuticals Market Size by Country/Region (2017-2022)
4.2.1 Global Radiopharmaceuticals Annual Sales by Country/Region (2017-2022)
4.2.2 Global Radiopharmaceuticals Annual Revenue by Country/Region
4.3 Americas Radiopharmaceuticals Sales Growth
4.4 APAC Radiopharmaceuticals Sales Growth
4.5 Europe Radiopharmaceuticals Sales Growth
4.6 Middle East & Africa Radiopharmaceuticals Sales Growth
5 Americas
5.1 Americas Radiopharmaceuticals Sales by Country
5.1.1 Americas Radiopharmaceuticals Sales by Country (2017-2022)
5.1.2 Americas Radiopharmaceuticals Revenue by Country (2017-2022)
5.2 Americas Radiopharmaceuticals Sales by Type
5.3 Americas Radiopharmaceuticals Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Radiopharmaceuticals Sales by Region
6.1.1 APAC Radiopharmaceuticals Sales by Region (2017-2022)
6.1.2 APAC Radiopharmaceuticals Revenue by Region (2017-2022)
6.2 APAC Radiopharmaceuticals Sales by Type
6.3 APAC Radiopharmaceuticals Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Radiopharmaceuticals by Country
7.1.1 Europe Radiopharmaceuticals Sales by Country (2017-2022)
7.1.2 Europe Radiopharmaceuticals Revenue by Country (2017-2022)
7.2 Europe Radiopharmaceuticals Sales by Type
7.3 Europe Radiopharmaceuticals Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Radiopharmaceuticals by Country
8.1.1 Middle East & Africa Radiopharmaceuticals Sales by Country (2017-2022)
8.1.2 Middle East & Africa Radiopharmaceuticals Revenue by Country (2017-2022)
8.2 Middle East & Africa Radiopharmaceuticals Sales by Type
8.3 Middle East & Africa Radiopharmaceuticals Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Radiopharmaceuticals
10.3 Manufacturing Process Analysis of Radiopharmaceuticals
10.4 Industry Chain Structure of Radiopharmaceuticals
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Radiopharmaceuticals Distributors
11.3 Radiopharmaceuticals Customer
12 World Forecast Review for Radiopharmaceuticals by Geographic Region
12.1 Global Radiopharmaceuticals Market Size Forecast by Region
12.1.1 Global Radiopharmaceuticals Forecast by Region (2023-2028)
12.1.2 Global Radiopharmaceuticals Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Radiopharmaceuticals Forecast by Type
12.7 Global Radiopharmaceuticals Forecast by Application
13 Key Players Analysis
13.1 Bracco Imaging
13.1.1 Bracco Imaging Company Information
13.1.2 Bracco Imaging Radiopharmaceuticals Product Offered
13.1.3 Bracco Imaging Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Bracco Imaging Main Business Overview
13.1.5 Bracco Imaging Latest Developments
13.2 Bayer
13.2.1 Bayer Company Information
13.2.2 Bayer Radiopharmaceuticals Product Offered
13.2.3 Bayer Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Bayer Main Business Overview
13.2.5 Bayer Latest Developments
13.3 Mallinckrodt
13.3.1 Mallinckrodt Company Information
13.3.2 Mallinckrodt Radiopharmaceuticals Product Offered
13.3.3 Mallinckrodt Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Mallinckrodt Main Business Overview
13.3.5 Mallinckrodt Latest Developments
13.4 Nordion
13.4.1 Nordion Company Information
13.4.2 Nordion Radiopharmaceuticals Product Offered
13.4.3 Nordion Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Nordion Main Business Overview
13.4.5 Nordion Latest Developments
13.5 Triad Isotopes
13.5.1 Triad Isotopes Company Information
13.5.2 Triad Isotopes Radiopharmaceuticals Product Offered
13.5.3 Triad Isotopes Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Triad Isotopes Main Business Overview
13.5.5 Triad Isotopes Latest Developments
13.6 Lantheus
13.6.1 Lantheus Company Information
13.6.2 Lantheus Radiopharmaceuticals Product Offered
13.6.3 Lantheus Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Lantheus Main Business Overview
13.6.5 Lantheus Latest Developments
13.7 IBA Group
13.7.1 IBA Group Company Information
13.7.2 IBA Group Radiopharmaceuticals Product Offered
13.7.3 IBA Group Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 IBA Group Main Business Overview
13.7.5 IBA Group Latest Developments
13.8 GE Healthcare
13.8.1 GE Healthcare Company Information
13.8.2 GE Healthcare Radiopharmaceuticals Product Offered
13.8.3 GE Healthcare Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 GE Healthcare Main Business Overview
13.8.5 GE Healthcare Latest Developments
13.9 China Isotope & Radiation
13.9.1 China Isotope & Radiation Company Information
13.9.2 China Isotope & Radiation Radiopharmaceuticals Product Offered
13.9.3 China Isotope & Radiation Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 China Isotope & Radiation Main Business Overview
13.9.5 China Isotope & Radiation Latest Developments
13.10 Jubilant Pharma
13.10.1 Jubilant Pharma Company Information
13.10.2 Jubilant Pharma Radiopharmaceuticals Product Offered
13.10.3 Jubilant Pharma Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Jubilant Pharma Main Business Overview
13.10.5 Jubilant Pharma Latest Developments
13.11 Eli Lilly
13.11.1 Eli Lilly Company Information
13.11.2 Eli Lilly Radiopharmaceuticals Product Offered
13.11.3 Eli Lilly Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Eli Lilly Main Business Overview
13.11.5 Eli Lilly Latest Developments
13.12 Advanced Accelerator Applications
13.12.1 Advanced Accelerator Applications Company Information
13.12.2 Advanced Accelerator Applications Radiopharmaceuticals Product Offered
13.12.3 Advanced Accelerator Applications Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Advanced Accelerator Applications Main Business Overview
13.12.5 Advanced Accelerator Applications Latest Developments
13.13 SIEMENS
13.13.1 SIEMENS Company Information
13.13.2 SIEMENS Radiopharmaceuticals Product Offered
13.13.3 SIEMENS Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 SIEMENS Main Business Overview
13.13.5 SIEMENS Latest Developments
13.14 Dongcheng
13.14.1 Dongcheng Company Information
13.14.2 Dongcheng Radiopharmaceuticals Product Offered
13.14.3 Dongcheng Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Dongcheng Main Business Overview
13.14.5 Dongcheng Latest Developments
13.15 Navidea
13.15.1 Navidea Company Information
13.15.2 Navidea Radiopharmaceuticals Product Offered
13.15.3 Navidea Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 Navidea Main Business Overview
13.15.5 Navidea Latest Developments
14 Research Findings and Conclusion
List of Tables
Table 1. Radiopharmaceuticals Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Radiopharmaceuticals Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Diagnostic Radioisotopes
Table 4. Major Players of Therapeutic Radioisotopes
Table 5. Global Radiopharmaceuticals Sales by Type (2017-2022) & (K Dose)
Table 6. Global Radiopharmaceuticals Sales Market Share by Type (2017-2022)
Table 7. Global Radiopharmaceuticals Revenue by Type (2017-2022) & ($ million)
Table 8. Global Radiopharmaceuticals Revenue Market Share by Type (2017-2022)
Table 9. Global Radiopharmaceuticals Sale Price by Type (2017-2022) & (US$/Dose)
Table 10. Global Radiopharmaceuticals Sales by Application (2017-2022) & (K Dose)
Table 11. Global Radiopharmaceuticals Sales Market Share by Application (2017-2022)
Table 12. Global Radiopharmaceuticals Revenue by Application (2017-2022)
Table 13. Global Radiopharmaceuticals Revenue Market Share by Application (2017-2022)
Table 14. Global Radiopharmaceuticals Sale Price by Application (2017-2022) & (US$/Dose)
Table 15. Global Radiopharmaceuticals Sales by Company (2020-2022) & (K Dose)
Table 16. Global Radiopharmaceuticals Sales Market Share by Company (2020-2022)
Table 17. Global Radiopharmaceuticals Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Radiopharmaceuticals Revenue Market Share by Company (2020-2022)
Table 19. Global Radiopharmaceuticals Sale Price by Company (2020-2022) & (US$/Dose)
Table 20. Key Manufacturers Radiopharmaceuticals Producing Area Distribution and Sales Area
Table 21. Players Radiopharmaceuticals Products Offered
Table 22. Radiopharmaceuticals Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Radiopharmaceuticals Sales by Geographic Region (2017-2022) & (K Dose)
Table 26. Global Radiopharmaceuticals Sales Market Share Geographic Region (2017-2022)
Table 27. Global Radiopharmaceuticals Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Radiopharmaceuticals Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Radiopharmaceuticals Sales by Country/Region (2017-2022) & (K Dose)
Table 30. Global Radiopharmaceuticals Sales Market Share by Country/Region (2017-2022)
Table 31. Global Radiopharmaceuticals Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Radiopharmaceuticals Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Radiopharmaceuticals Sales by Country (2017-2022) & (K Dose)
Table 34. Americas Radiopharmaceuticals Sales Market Share by Country (2017-2022)
Table 35. Americas Radiopharmaceuticals Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Radiopharmaceuticals Revenue Market Share by Country (2017-2022)
Table 37. Americas Radiopharmaceuticals Sales by Type (2017-2022) & (K Dose)
Table 38. Americas Radiopharmaceuticals Sales Market Share by Type (2017-2022)
Table 39. Americas Radiopharmaceuticals Sales by Application (2017-2022) & (K Dose)
Table 40. Americas Radiopharmaceuticals Sales Market Share by Application (2017-2022)
Table 41. APAC Radiopharmaceuticals Sales by Region (2017-2022) & (K Dose)
Table 42. APAC Radiopharmaceuticals Sales Market Share by Region (2017-2022)
Table 43. APAC Radiopharmaceuticals Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Radiopharmaceuticals Revenue Market Share by Region (2017-2022)
Table 45. APAC Radiopharmaceuticals Sales by Type (2017-2022) & (K Dose)
Table 46. APAC Radiopharmaceuticals Sales Market Share by Type (2017-2022)
Table 47. APAC Radiopharmaceuticals Sales by Application (2017-2022) & (K Dose)
Table 48. APAC Radiopharmaceuticals Sales Market Share by Application (2017-2022)
Table 49. Europe Radiopharmaceuticals Sales by Country (2017-2022) & (K Dose)
Table 50. Europe Radiopharmaceuticals Sales Market Share by Country (2017-2022)
Table 51. Europe Radiopharmaceuticals Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Radiopharmaceuticals Revenue Market Share by Country (2017-2022)
Table 53. Europe Radiopharmaceuticals Sales by Type (2017-2022) & (K Dose)
Table 54. Europe Radiopharmaceuticals Sales Market Share by Type (2017-2022)
Table 55. Europe Radiopharmaceuticals Sales by Application (2017-2022) & (K Dose)
Table 56. Europe Radiopharmaceuticals Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Radiopharmaceuticals Sales by Country (2017-2022) & (K Dose)
Table 58. Middle East & Africa Radiopharmaceuticals Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Radiopharmaceuticals Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Radiopharmaceuticals Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Radiopharmaceuticals Sales by Type (2017-2022) & (K Dose)
Table 62. Middle East & Africa Radiopharmaceuticals Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Radiopharmaceuticals Sales by Application (2017-2022) & (K Dose)
Table 64. Middle East & Africa Radiopharmaceuticals Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Radiopharmaceuticals
Table 66. Key Market Challenges & Risks of Radiopharmaceuticals
Table 67. Key Industry Trends of Radiopharmaceuticals
Table 68. Radiopharmaceuticals Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Radiopharmaceuticals Distributors List
Table 71. Radiopharmaceuticals Customer List
Table 72. Global Radiopharmaceuticals Sales Forecast by Region (2023-2028) & (K Dose)
Table 73. Global Radiopharmaceuticals Sales Market Forecast by Region
Table 74. Global Radiopharmaceuticals Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Radiopharmaceuticals Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Radiopharmaceuticals Sales Forecast by Country (2023-2028) & (K Dose)
Table 77. Americas Radiopharmaceuticals Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Radiopharmaceuticals Sales Forecast by Region (2023-2028) & (K Dose)
Table 79. APAC Radiopharmaceuticals Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Radiopharmaceuticals Sales Forecast by Country (2023-2028) & (K Dose)
Table 81. Europe Radiopharmaceuticals Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Radiopharmaceuticals Sales Forecast by Country (2023-2028) & (K Dose)
Table 83. Middle East & Africa Radiopharmaceuticals Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Radiopharmaceuticals Sales Forecast by Type (2023-2028) & (K Dose)
Table 85. Global Radiopharmaceuticals Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Radiopharmaceuticals Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Radiopharmaceuticals Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Radiopharmaceuticals Sales Forecast by Application (2023-2028) & (K Dose)
Table 89. Global Radiopharmaceuticals Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Radiopharmaceuticals Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Radiopharmaceuticals Revenue Market Share Forecast by Application (2023-2028)
Table 92. Bracco Imaging Basic Information, Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 93. Bracco Imaging Radiopharmaceuticals Product Offered
Table 94. Bracco Imaging Radiopharmaceuticals Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 95. Bracco Imaging Main Business
Table 96. Bracco Imaging Latest Developments
Table 97. Bayer Basic Information, Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 98. Bayer Radiopharmaceuticals Product Offered
Table 99. Bayer Radiopharmaceuticals Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 100. Bayer Main Business
Table 101. Bayer Latest Developments
Table 102. Mallinckrodt Basic Information, Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 103. Mallinckrodt Radiopharmaceuticals Product Offered
Table 104. Mallinckrodt Radiopharmaceuticals Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 105. Mallinckrodt Main Business
Table 106. Mallinckrodt Latest Developments
Table 107. Nordion Basic Information, Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 108. Nordion Radiopharmaceuticals Product Offered
Table 109. Nordion Radiopharmaceuticals Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 110. Nordion Main Business
Table 111. Nordion Latest Developments
Table 112. Triad Isotopes Basic Information, Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 113. Triad Isotopes Radiopharmaceuticals Product Offered
Table 114. Triad Isotopes Radiopharmaceuticals Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 115. Triad Isotopes Main Business
Table 116. Triad Isotopes Latest Developments
Table 117. Lantheus Basic Information, Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 118. Lantheus Radiopharmaceuticals Product Offered
Table 119. Lantheus Radiopharmaceuticals Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 120. Lantheus Main Business
Table 121. Lantheus Latest Developments
Table 122. IBA Group Basic Information, Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 123. IBA Group Radiopharmaceuticals Product Offered
Table 124. IBA Group Radiopharmaceuticals Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 125. IBA Group Main Business
Table 126. IBA Group Latest Developments
Table 127. GE Healthcare Basic Information, Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 128. GE Healthcare Radiopharmaceuticals Product Offered
Table 129. GE Healthcare Radiopharmaceuticals Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 130. GE Healthcare Main Business
Table 131. GE Healthcare Latest Developments
Table 132. China Isotope & Radiation Basic Information, Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 133. China Isotope & Radiation Radiopharmaceuticals Product Offered
Table 134. China Isotope & Radiation Radiopharmaceuticals Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 135. China Isotope & Radiation Main Business
Table 136. China Isotope & Radiation Latest Developments
Table 137. Jubilant Pharma Basic Information, Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 138. Jubilant Pharma Radiopharmaceuticals Product Offered
Table 139. Jubilant Pharma Radiopharmaceuticals Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 140. Jubilant Pharma Main Business
Table 141. Jubilant Pharma Latest Developments
Table 142. Eli Lilly Basic Information, Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 143. Eli Lilly Radiopharmaceuticals Product Offered
Table 144. Eli Lilly Radiopharmaceuticals Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 145. Eli Lilly Main Business
Table 146. Eli Lilly Latest Developments
Table 147. Advanced Accelerator Applications Basic Information, Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 148. Advanced Accelerator Applications Radiopharmaceuticals Product Offered
Table 149. Advanced Accelerator Applications Radiopharmaceuticals Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 150. Advanced Accelerator Applications Main Business
Table 151. Advanced Accelerator Applications Latest Developments
Table 152. SIEMENS Basic Information, Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 153. SIEMENS Radiopharmaceuticals Product Offered
Table 154. SIEMENS Radiopharmaceuticals Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 155. SIEMENS Main Business
Table 156. SIEMENS Latest Developments
Table 157. Dongcheng Basic Information, Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 158. Dongcheng Radiopharmaceuticals Product Offered
Table 159. Dongcheng Radiopharmaceuticals Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 160. Dongcheng Main Business
Table 161. Dongcheng Latest Developments
Table 162. Navidea Basic Information, Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 163. Navidea Radiopharmaceuticals Product Offered
Table 164. Navidea Radiopharmaceuticals Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 165. Navidea Main Business
Table 166. Navidea Latest Developments
List of Figures
Figure 1. Picture of Radiopharmaceuticals
Figure 2. Radiopharmaceuticals Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Radiopharmaceuticals Sales Growth Rate 2017-2028 (K Dose)
Figure 7. Global Radiopharmaceuticals Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Radiopharmaceuticals Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Diagnostic Radioisotopes
Figure 10. Product Picture of Therapeutic Radioisotopes
Figure 11. Global Radiopharmaceuticals Sales Market Share by Type in 2021
Figure 12. Global Radiopharmaceuticals Revenue Market Share by Type (2017-2022)
Figure 13. Radiopharmaceuticals Consumed in Oncology
Figure 14. Global Radiopharmaceuticals Market: Oncology (2017-2022) & (K Dose)
Figure 15. Radiopharmaceuticals Consumed in Cardiology
Figure 16. Global Radiopharmaceuticals Market: Cardiology (2017-2022) & (K Dose)
Figure 17. Radiopharmaceuticals Consumed in Other
Figure 18. Global Radiopharmaceuticals Market: Other (2017-2022) & (K Dose)
Figure 19. Global Radiopharmaceuticals Sales Market Share by Application (2017-2022)
Figure 20. Global Radiopharmaceuticals Revenue Market Share by Application in 2021
Figure 21. Radiopharmaceuticals Revenue Market by Company in 2021 ($ Million)
Figure 22. Global Radiopharmaceuticals Revenue Market Share by Company in 2021
Figure 23. Global Radiopharmaceuticals Sales Market Share by Geographic Region (2017-2022)
Figure 24. Global Radiopharmaceuticals Revenue Market Share by Geographic Region in 2021
Figure 25. Global Radiopharmaceuticals Sales Market Share by Region (2017-2022)
Figure 26. Global Radiopharmaceuticals Revenue Market Share by Country/Region in 2021
Figure 27. Americas Radiopharmaceuticals Sales 2017-2022 (K Dose)
Figure 28. Americas Radiopharmaceuticals Revenue 2017-2022 ($ Millions)
Figure 29. APAC Radiopharmaceuticals Sales 2017-2022 (K Dose)
Figure 30. APAC Radiopharmaceuticals Revenue 2017-2022 ($ Millions)
Figure 31. Europe Radiopharmaceuticals Sales 2017-2022 (K Dose)
Figure 32. Europe Radiopharmaceuticals Revenue 2017-2022 ($ Millions)
Figure 33. Middle East & Africa Radiopharmaceuticals Sales 2017-2022 (K Dose)
Figure 34. Middle East & Africa Radiopharmaceuticals Revenue 2017-2022 ($ Millions)
Figure 35. Americas Radiopharmaceuticals Sales Market Share by Country in 2021
Figure 36. Americas Radiopharmaceuticals Revenue Market Share by Country in 2021
Figure 37. United States Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions)
Figure 38. Canada Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions)
Figure 39. Mexico Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions)
Figure 40. Brazil Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions)
Figure 41. APAC Radiopharmaceuticals Sales Market Share by Region in 2021
Figure 42. APAC Radiopharmaceuticals Revenue Market Share by Regions in 2021
Figure 43. China Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions)
Figure 44. Japan Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions)
Figure 45. South Korea Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions)
Figure 46. Southeast Asia Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions)
Figure 47. India Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions)
Figure 48. Australia Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions)
Figure 49. Europe Radiopharmaceuticals Sales Market Share by Country in 2021
Figure 50. Europe Radiopharmaceuticals Revenue Market Share by Country in 2021
Figure 51. Germany Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions)
Figure 52. France Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions)
Figure 53. UK Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions)
Figure 54. Italy Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions)
Figure 55. Russia Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions)
Figure 56. Middle East & Africa Radiopharmaceuticals Sales Market Share by Country in 2021
Figure 57. Middle East & Africa Radiopharmaceuticals Revenue Market Share by Country in 2021
Figure 58. Egypt Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions)
Figure 59. South Africa Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions)
Figure 60. Israel Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions)
Figure 61. Turkey Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions)
Figure 62. GCC Country Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions)
Figure 63. Manufacturing Cost Structure Analysis of Radiopharmaceuticals in 2021
Figure 64. Manufacturing Process Analysis of Radiopharmaceuticals
Figure 65. Industry Chain Structure of Radiopharmaceuticals
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
